Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nisanne S Ghonem

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Hepatology (Baltimore, Md.)|November 24, 2012
Fibrates as adjuvant therapy for chronic cholestatic liver disease: its time has comeNisanne S Ghonem, James L Boyer
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|September 24, 2021
Treprostinil alleviates hepatic mitochondrial injury during rat renal ischemia-reperfusion injuryJoyce Hou, Evelyn Tolbert, Mark Birkenbach, et al.
Hepatology (Baltimore, Md.)|February 14, 2015
Fibrates and cholestasisNisanne S Ghonem, David N Assis, James L Boyer
Hepatology (Baltimore, Md.)|October 15, 2013
Peroxisome proliferator-activated receptor α activates human multidrug resistance transporter 3/ATP-binding cassette protein subfamily B4 transcription and increases rat biliary phosphatidylcholine secretionNisanne S Ghonem, Meenakshisundaram Ananthanarayanan, Carol J Soroka, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|July 30, 2021
Treprostinil reduces mitochondrial injury during rat renal ischemia-reperfusion injuryMeiwen Ding, Evelyn Tolbert, Mark Birkenbach, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|November 6, 2020
Treprostinil, a prostacyclin analog, ameliorates renal ischemia-reperfusion injury: preclinical studies in a rat model of acute kidney injuryMeiwen Ding, Evelyn Tolbert, Mark Birkenbach, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|June 30, 2024
Quantification of treprostinil concentration in rat and human using a novel validated and rapid liquid chromatography-tandem mass spectrometry method: Experimental and clinical applications in ischemia-reperfusion injuryGina M Gallucci, Mariam Oladepo Agbabiaka, Meiwen Ding, et al.
Hepatology Communications|December 19, 2024
PPAR agonists for the treatment of cholestatic liver diseases: Over a decade of clinical progressColleen M Hayes, Gina M Gallucci, James L Boyer, et al.
Journal of Pharmaceutical and Biomedical Analysis|February 3, 2026
Corrigendum to 'A liquid biopsy-RNAseq method for monitoring the expression of genes involved in drug disposition: proof-of-concept application to cholestatic liver disease' [J. Pharm. Biomed. Anal. (2025) 269: 117244]Amit Dahal, Teresa Sierra, Colleen M Hayes, et al.
Inflammation|July 15, 2022
Fenofibrate Downregulates NF-κB Signaling to Inhibit Pro-inflammatory Cytokine Secretion in Human THP-1 Macrophages and During Primary Biliary CholangitisGina M Gallucci, Bader Alsuwayt, Adam M Auclair, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Hepatology (Baltimore, Md.)|November 24, 2012
Fibrates as adjuvant therapy for chronic cholestatic liver disease: its time has comeNisanne S Ghonem, James L Boyer
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|September 24, 2021
Treprostinil alleviates hepatic mitochondrial injury during rat renal ischemia-reperfusion injuryJoyce Hou, Evelyn Tolbert, Mark Birkenbach, et al.
Hepatology (Baltimore, Md.)|February 14, 2015
Fibrates and cholestasisNisanne S Ghonem, David N Assis, James L Boyer
Hepatology (Baltimore, Md.)|October 15, 2013
Peroxisome proliferator-activated receptor α activates human multidrug resistance transporter 3/ATP-binding cassette protein subfamily B4 transcription and increases rat biliary phosphatidylcholine secretionNisanne S Ghonem, Meenakshisundaram Ananthanarayanan, Carol J Soroka, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|July 30, 2021
Treprostinil reduces mitochondrial injury during rat renal ischemia-reperfusion injuryMeiwen Ding, Evelyn Tolbert, Mark Birkenbach, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|November 6, 2020
Treprostinil, a prostacyclin analog, ameliorates renal ischemia-reperfusion injury: preclinical studies in a rat model of acute kidney injuryMeiwen Ding, Evelyn Tolbert, Mark Birkenbach, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|June 30, 2024
Quantification of treprostinil concentration in rat and human using a novel validated and rapid liquid chromatography-tandem mass spectrometry method: Experimental and clinical applications in ischemia-reperfusion injuryGina M Gallucci, Mariam Oladepo Agbabiaka, Meiwen Ding, et al.
Hepatology Communications|December 19, 2024
PPAR agonists for the treatment of cholestatic liver diseases: Over a decade of clinical progressColleen M Hayes, Gina M Gallucci, James L Boyer, et al.
Journal of Pharmaceutical and Biomedical Analysis|February 3, 2026
Corrigendum to 'A liquid biopsy-RNAseq method for monitoring the expression of genes involved in drug disposition: proof-of-concept application to cholestatic liver disease' [J. Pharm. Biomed. Anal. (2025) 269: 117244]Amit Dahal, Teresa Sierra, Colleen M Hayes, et al.
Inflammation|July 15, 2022
Fenofibrate Downregulates NF-κB Signaling to Inhibit Pro-inflammatory Cytokine Secretion in Human THP-1 Macrophages and During Primary Biliary CholangitisGina M Gallucci, Bader Alsuwayt, Adam M Auclair, et al.
Pageof 2